US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
RSS Feeds

Biotechnology market research reports and industry analysis

2  3  4  5    7    9  10  11  
OPERON S.A - Product Pipeline Analysis, 2014 Update
7/15/2014 | published by: GlobalData
... CD2WB, chagas WB, lisaKIT PSA, lisaKIT AFP, lisaKIT toxo IgG, HLA B5701 strip, HPV – low risk, HPV – high+low risk, hemochromastrip and others. Operon offers services, such as manufacturing in OEM format, and lateral ...  |  read more...
USD 750
Oxford Gene Technology - Product Pipeline Analysis, 2014 Update
7/15/2014 | published by: GlobalData
... sample tracking spike-ins and CytoSure syndrome Plus v2 array. OGT offers services, such as targeted sequencing services, SureSeq Solid Tumour Panel Sequencing Service, RNA-Seq service, miRNA analysis, gene expression analysis, cytosure services and aCGH for ...  |  read more...
USD 750
Panacea Biotec Limited (PANACEABIO) - Financial and Strategic SWOT Analysis Review
7/15/2014 | published by: GlobalData
... you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand ...  |  read more...
USD 125
Pantec Biosolutions AG - Product Pipeline Analysis, 2014 Update
7/15/2014 | published by: GlobalData
... medical solutions and (P.L.E.A.S.E.) painless laser epidermal system devices. Pantec provides needless therapy by a convenient intraepidermal method and also develops its P.L.E.A.S.E. platform for active intraepider delivery of biopharmaceuticals such as hormones, proteins, peptides ...  |  read more...
USD 750
PrognosDx Health, Inc. - Product Pipeline Analysis, 2014 Update
7/15/2014 | published by: GlobalData
... treatment of prostate cancer and bladder cancer. The company’s rxscore is a therapeutic test for pancreatic, breast, colorectal, and lung cancers. The company conducts clinical validation studies at medical centers throughout the US. PrognosDx is ...  |  read more...
USD 750
Protagen AG - Product Pipeline Analysis, 2014 Update
7/15/2014 | published by: GlobalData
... lupus erythematosus, ankylosing spondylitis, systemic sclerosis, multiple sclerosis and neuromyelitis optical. Protagen’s serotag biomarker development engine delivers biomarker signatures. The company also provides support services throughout the diagnostic test development and implementation process, and provides ...  |  read more...
USD 750
Celera Group : Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
7/15/2014 | published by: MarketLine
... and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Celera Group Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers ...  |  read more...
USD 350
Charles River Laboratories International, Inc. : Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
7/15/2014 | published by: MarketLine
... of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Charles River Laboratories International, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes ...  |  read more...
USD 350
Genetic Technologies Limited : Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
7/15/2014 | published by: MarketLine
... organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Genetic Technologies Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports ...  |  read more...
USD 350
Lonza Group, Ltd. : Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
7/15/2014 | published by: MarketLine
... organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Lonza Group, Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports ...  |  read more...
USD 350
TiGenix N.V. : Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
7/15/2014 | published by: MarketLine
... and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' TiGenix N.V. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers ...  |  read more...
USD 350
International Stem Cell Corporation : Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
7/15/2014 | published by: MarketLine
... the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' International Stem Cell Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, ...  |  read more...
USD 350
Immunocellular Therapeutics, Ltd. (formerly Optical Molecular Imaging, Inc.) : Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
7/15/2014 | published by: MarketLine
... a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Immunocellular Therapeutics, Ltd. (formerly Optical Molecular Imaging, Inc.) Mergers & Acquisitions (M&A), Partnerships ...  |  read more...
USD 350
Oxygen Biotherapeutics, Inc. (formerly Synthetic Blood International, Inc.) : Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
7/15/2014 | published by: MarketLine
... a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Oxygen Biotherapeutics, Inc. (formerly Synthetic Blood International, Inc.) Mergers & Acquisitions (M&A), Partnerships ...  |  read more...
USD 350
Sorrento Therapeutics, Inc. : Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
7/15/2014 | published by: MarketLine
... organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Sorrento Therapeutics, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports ...  |  read more...
USD 350
BG Medicine, Inc. : Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
7/15/2014 | published by: MarketLine
... organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' BG Medicine, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports ...  |  read more...
USD 350
Novartis AG : Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
7/15/2014 | published by: MarketLine
... and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Novartis AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers ...  |  read more...
USD 350
Champions Oncology, Inc. (formerly Champions Biotechnology, Inc.) : Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
7/15/2014 | published by: MarketLine
... comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Champions Oncology, Inc. (formerly Champions Biotechnology, Inc.) Mergers & Acquisitions (M&A), Partnerships & Alliances ...  |  read more...
USD 350
Celsion Corporation : Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
7/15/2014 | published by: MarketLine
... and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Celsion Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers ...  |  read more...
USD 350
Janssen Biotech, Inc. (formerly Centocor Ortho Biotech, Inc.) : Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
7/15/2014 | published by: MarketLine
... a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Janssen Biotech, Inc. (formerly Centocor Ortho Biotech, Inc.) Mergers & Acquisitions (M&A), Partnerships ...  |  read more...
USD 350
Genentech, Inc. : Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
7/15/2014 | published by: MarketLine
... and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Genentech, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers ...  |  read more...
USD 350
Covance, Inc. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
7/15/2014 | published by: MarketLine
... and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Covance, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers ...  |  read more...
USD 350
Prana Biotechnology Limited - Product Pipeline Review - 2014
7/15/2014 | published by: Global Markets Direct
... focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Prana Biotechnology Limited’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration ...  |  read more...
USD 1,500
Neuralstem, Inc. - Product Pipeline Review - 2014
7/15/2014 | published by: Global Markets Direct
... provides comprehensive information on the current therapeutic developmental pipeline of Neuralstem, Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. ...  |  read more...
USD 1,500
Global Metabolomics Market : 2014-2018
7/14/2014 | published by: TechNavio - Infiniti Research Ltd.
... Laboratories Inc., Bruker Corp., Human Metabolome Technologies Inc., Metabolon Inc. , Acadia Pharmaceuticals , Accelrys, BG Medicine, Biocrates Life Sciences, Chenomx, Life Technologies, Metabolomic Technologies , Nanosyn, PerkinElmer, WatersCommenting on the report, an analyst from ...  |  read more...
USD 2,500
2  3  4  5    7    9  10  11